From the Departments of Pediatrics and.
Allergy Asthma Proc. 2022 Sep 1;43(5):368-374. doi: 10.2500/aap.2022.43.220059.
The long coronavirus disease 2019 (COVID-19) syndrome includes a group of patients who, after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit lingering mild-to-moderate symptoms and develop medical complications that can have lasting health problems. The purpose of this report was to examine the current body of evidence that deals with the relationship of COVID-19 infection with the long COVID syndrome to define the possible immunologic mechanisms involved in the pathogenesis of long COVID and to describe potential strategies for the diagnosis and clinical management of the condition. Extensive research was conducted in medical literature data bases by applying terms such as long COVID, post-COVID-19 condition, pathogenesis of long COVID, management of the long COVID syndrome. The post-COVID conditions, a more recent and less anxiety-inducing term for the patient than long COVID or "long haul," is an umbrella term for a wide range of physical and mental health symptoms similar to those seen in patients with the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), experienced by some patients and are present ≥ 4 weeks after SARS-CoV-2 infection. Although the precise reason why long COVID develops is unknown, one of the major causes is thought to be related to chronic inflammation with overproduction of inflammatory cytokines responsible for the symptoms of the disorder. Long COVID is a growing burden for millions of patients, health-care providers, and global health-care systems, and is a particular challenge for the allergist/immunologist. Many survivors of COVID-19 struggle with multiple symptoms, increased disability, reduced function, and poor quality of life. The allergist/immunologist can assist the total health-care team's efforts in providing a comprehensive and coordinated approach to the management of these patients by promoting comprehensive vaccination and rehabilitation and social services that focus on improving physical, mental, and social well-being, and by establishing partnerships with specialists and other health-care professionals who can provide behavioral, lifestyle, and integrative approaches that may have much to offer in helping patients cope with their symptoms.
长新冠疾病 2019(COVID-19)综合征包括一组患者,他们在感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)后出现持续的轻度至中度症状,并出现可能导致长期健康问题的医疗并发症。本报告的目的是检查目前与 COVID-19 感染与长新冠综合征之间关系的证据,以确定长新冠发病机制中涉及的可能免疫机制,并描述该疾病的诊断和临床管理的潜在策略。通过应用长新冠、新冠后状况、长新冠发病机制、长新冠综合征管理等术语,在医学文献数据库中进行了广泛的研究。新冠后状况是一个比长新冠或“long haul”更新颖、不太令人焦虑的术语,是一个广泛的身体和心理健康症状的总称,类似于一些患者经历的肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)患者的症状,这些症状出现在 SARS-CoV-2 感染后≥4 周。虽然长新冠发展的确切原因尚不清楚,但一个主要原因被认为与慢性炎症有关,炎症细胞因子过度产生导致该疾病的症状。长新冠对数百万患者、医疗保健提供者和全球医疗保健系统来说是一个日益严重的负担,对过敏学家/免疫学家来说是一个特别的挑战。许多 COVID-19 的幸存者都面临多种症状、残疾增加、功能下降和生活质量差的问题。过敏学家/免疫学家可以通过促进全面疫苗接种和康复以及社会服务,专注于改善身体、心理和社会福祉,与专家和其他医疗保健专业人员建立伙伴关系,为这些患者提供全面和协调的管理方法,来协助整个医疗保健团队的努力,这些专家和其他医疗保健专业人员可以提供行为、生活方式和综合方法,这可能对帮助患者应对症状有很大帮助。